{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:26:52Z","timestamp":1789586812489,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaip.2017.03.035","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T11:30:14Z","timestamp":1495625414000},"page":"1601-1606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Opioid Hypersensitivity: Predictors of Allergy and Role of Drug Provocation Testing"],"prefix":"10.1016","volume":"5","author":[{"given":"Philip H.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Loong","family":"Ue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.03.035_bib1","doi-asserted-by":"crossref","unstructured":"International Narcotics Control Board. Narcotic Drugs: Estimated World Requirements for 2016\u2014Statistics for 2014; 2016. Available at: http:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2015\/NAR-tech_pub_2015.pdf. Accessed March 24, 2017.","DOI":"10.18356\/69254972-en-fr-es"},{"key":"10.1016\/j.jaip.2017.03.035_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: an 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.035_bib3","first-page":"868","article-title":"Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007)","volume":"78","author":"Dong","year":"2012","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jaip.2017.03.035_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jaip.2017.03.035_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1213\/00000539-198509000-00009","article-title":"Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: a double-blind study","volume":"64","author":"Flacke","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2017.03.035_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1046\/j.1365-2222.2001.01090.x","article-title":"Opiate-sensitivity: clinical characteristics and the role of skin prick testing","volume":"31","author":"Nasser","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00000542-199211000-00016","article-title":"Human basophil\/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release","volume":"77","author":"Stellato","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2017.03.035_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02074699","article-title":"Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol","volume":"20","author":"Barth","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2017.03.035_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaip.2014.12.002","article-title":"IgE to poppy seed and morphine are not useful tools to diagnose opiate allergy","volume":"3","author":"Van Gasse","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.03.035_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1399-6576.2004.00591.x","article-title":"Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively","volume":"49","author":"Florvaag","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaip.2017.03.035_bib12","series-title":"Drug Allergy. Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships","first-page":"308","author":"Baldo","year":"2013"},{"key":"10.1016\/j.jaip.2017.03.035_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.035_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resuscitation.2008.02.001","article-title":"Emergency treatment of anaphylactic reactions\u2014guidelines for healthcare providers","volume":"77","author":"Soar","year":"2008","journal-title":"Resuscitation"},{"key":"10.1016\/j.jaip.2017.03.035_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaip.2017.03.035_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cea.12177","article-title":"Allergy to illicit drugs and narcotics","volume":"44","author":"Swerts","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1398-9995.2009.02113.x","article-title":"Codeine-induced generalized dermatitis and tolerance to other opioids","volume":"64","author":"Orjales","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4168\/aair.2014.6.1.95","article-title":"A\u00a0case of codeine induced anaphylaxis via oral route","volume":"6","author":"Yoo","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2017.03.035_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1398-9995.2000.00556.x","article-title":"Fever and urticaria to codeine","volume":"55","author":"Vidal","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1398-9995.2005.00715.x","article-title":"Allergy to pholcodine: first case documented by oral challenge","volume":"60","author":"Codreanu","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1157\/13094030","article-title":"Pharmacological stimuli in asthma\/urticaria","volume":"34","author":"Prieto-Lastra","year":"2006","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2017.03.035_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aller.2012.04.010","article-title":"The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study","volume":"41","author":"Celebioglu","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2017.03.035_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1157\/13112997","article-title":"Codeine challenge in chronic urticaria patients","volume":"35","author":"Giavina-Bianchi","year":"2007","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2017.03.035_bib24","first-page":"56","article-title":"Chronic urticaria with multiple NSAID intolerance: is tramadol always a safe alternative analgesic?","volume":"13","author":"Asero","year":"2003","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.035_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update","volume":"95","author":"Crews","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.03.035_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.035_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000542-198310000-00011","article-title":"Histamine release by narcotics and muscle relaxants in humans","volume":"59","author":"Moss","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2017.03.035_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(96)90151-4","article-title":"Morphine-induced venodilation in humans","volume":"60","author":"Grossmann","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.03.035_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00000542-198109000-00019","article-title":"The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study","volume":"55","author":"Philbin","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2017.03.035_bib30","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells","volume":"155","author":"Fureder","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2017.03.035_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI113403","article-title":"Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release","volume":"81","author":"Schulman","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2017.03.035_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/1523-1747.ep12378589","article-title":"Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells","volume":"102","author":"el-Lati","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2017.03.035_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0091-6749(87)80162-8","article-title":"Functional heterogeneity of human mast cells from different anatomic sites: in\u00a0vitro responses to morphine sulfate","volume":"79","author":"Tharp","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.035_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1399-6576.2009.02044.x","article-title":"The investigation of bronchospasm during induction of anaesthesia","volume":"53","author":"Fisher","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaip.2017.03.035_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000542-200309000-00007","article-title":"Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000","volume":"99","author":"Mertes","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2017.03.035_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1213\/01.ANE.0000097168.32472.0D","article-title":"Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in\u00a0vivo microdialysis study in human skin","volume":"98","author":"Blunk","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2017.03.035_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cyto.b.21074","article-title":"IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: lessons from flow cytometry","volume":"84","author":"Leysen","year":"2013","journal-title":"Cytometry B Clin Cytom"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:44Z","timestamp":1761974024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817302490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213219817302490"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.035","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Hypersensitivity: Predictors of Allergy and Role of Drug Provocation Testing","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}